MCK - Mckesson Corp Stock Analysis
Mckesson Corp (MCK) is a publicly traded company listed on the . It operates in the industry, part of the broader sector. The company has a market capitalization of 102.02B, generates annual revenue of 410.98B, and reports net income of 4.59B. As of the latest data, the stock is trading at 871.38 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company has very low leverage, which may indicate conservative financial management or underutilization of debt. The dividend yield (0.37%) is modest, often associated with growth-oriented companies. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Buy (4.26), indicating current market sentiment. Institutional ownership is reported at 93.93%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 23.82%, trading within a 52-week range of 637.00 - 999.00.
MCK - Mckesson Corp
871.38
Analyst Consensus
Buy 4.26
MCK – Analyst Rating Summary
- Strong Buy: 9
- Buy: 11
- Hold: 3
- Sell: 0
- Strong Sell: 0
- Total Analysts: 23
| Index: | S&P 500 | P/E: | 23.32 | EPS (ttm): | 37.37 | Insider Own: | 0.05% | Shs Outstand: | 117.08M | Perf Week: | 0.68% |
| Market Cap: | 102.02B | Forward P/E: | 17.26 | EPS next Y: | 50.48 | Insider Trans: | -37.05% | Shs Float: | 117.02M | Perf Month: | 6.44% |
| Income(ttm): | 4.59B | PEG: | 1.26 | EPS next Q: | 10.75 | Inst Own: | 93.93% | Short Float: | 3.31% | Perf Quarter: | 17.17% |
| Revenue(ttm): | 410.98B | P/S: | 0.25 | EPS this Y: | 13.80% | Inst Trans: | -1.66% | Short Ratio: | 3.24 | Perf Half Y: | 6.01% |
| Book/sh: | -36.55 | P/B: | - | EPS next Y: | 13.42% | ROA: | 5.41% | Short Interest: | 3.88M | Perf Year: | 23.82% |
| Cash/sh: | 44.11 | P/C: | 19.76 | EPS next 5Y: | 13.67% | ROE: | - | 52W Range: | 637.00 - 999.00 | Perf YTD: | 6.23% |
| Dividend Est.: | 3.23 (0.37%) | P/FCF: | 15.90 | EPS past 3/5Y: | 15.30% - | ROIC: | 78.20% | 52W High: | 999.00 -12.77% | Beta: | 0.30 |
| Dividend TTM: | 3.28 (0.38%) | Quick Ratio: | 0.52 | Sales past 3/5Y: | 13.39% 11.11% | Gross Margin: | 3.48% | 52W Low: | 637.00 36.79% | Perf 5Y: | 335.84% |
| Dividend Ex-Date: | Sep 01, 2026 | Current Ratio: | 0.89 | EPS Y/Y TTM: | 48.98% | Oper. Margin: | 1.63% | RSI (14): | 60.12 | Volatility: | 4.73% 3.06% |
| Employees: | 43000 | Debt/Eq: | - | Sales Y/Y TTM: | 8.84% | Profit Margin: | 1.12% | Recom: | 1.43 | Target Price: | 986.13 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | - | EPS Q/Q: | -17.56% | Payout: | 8.26% | Rel Volume: | 1.34 | Prev Close: | 877.23 |
| Sales Surprise: | 1.45% | EPS Surprise: | 3.86% | Sales Q/Q: | 7.72% | Earnings: | Aug 05 AMC | Avg Volume: | 1.20M | Price: | 871.38 |
| SMA20: | 3.76% | SMA50: | 9.28% | SMA200: | 4.08% | Undervalued: 13.17% | Volume: | 1,607,599 | Change: | -0.67% | |
Graham Classic formula value: 1202.67
(P/E=8 * 1g) Min value: 727.17
(current P/E * 2g) Max value: 1699.98
Average value: 1209.94
About Mckesson Corp
McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.